Risk factors for development of anti-adalimumab antibodies in non-infectious uveitis

被引：0
|
作者：
Bromeo, Albert [1 ]
Karaca, Irmak [1 ]
Ghoraba, Hashem [1 ]
Lyu, Xun [1 ]
Akhavanrezayat, Amir [1 ]
Uludag, Gunay [1 ]
Than, Ngoc [1 ]
Ongpalakorn, Prapatsorn [1 ]
Shin, YongUn [1 ]
Tran, Anh [1 ]
Yavari, Negin [1 ]
Khojasteh, Hassan [1 ]
Bazojoo, Vahid [1 ]
Ahmed, Mohamed [2 ]
Or, Chris [1 ]
Nguyen, Quan [1 ]
机构：
[1] Stanford Univ, Palo Alto, CA USA
[2] Ocular Imaging Res & Reading Ctr, Sunnyvale, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Risk factors for development of anti-adalimumab antibodies in non-infectious uveitis
    Bromeo, Albert John
    Karaca, Irmak
    Ghoraba, Hashem H.
    Lyu, Xun
    Trong, Ngoc
    Than, Tuong
    Ongpalakorn, Prapatsorn
    Shin, Yong Un
    Uludag, Gunay
    Tran, Anh Ngoc Tram
    Thng, Zheng Xian
    V. Do, Diana
    Mong, Chi
    Or, Christopher
    Nguyen, Quan Dong
    HELIYON, 2024, 10 (09)
  • [2] Trough levels of adalimumab and the appearances of anti-adalimumab antibody in non-infectious uveitis patients treated with Adalimumab
    Suzuki, K.
    Iwata, D.
    Namba, K.
    Mizuuchi, K.
    Fukuhara, T.
    Ohno, S.
    Kitaichi, N.
    Ishida, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S174 - S174
  • [3] Anti-adalimumab Antibodies in Patients with Non-infectious Ocular Inflammatory Disease: A Case Series
    McKay, K. Matthew
    Apostolopoulos, Nicholas
    Chou, Brian
    Leveque, Thellea K.
    Van Gelder, Russell N.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (7-8) : 1721 - 1725
  • [4] Adalimumab in the treatment of non-infectious uveitis
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (10): : 1231 - 1236
  • [5] The effectiveness of adalimumab treatment for non-infectious uveitis
    Hasegawa, Eiichi
    Takeda, Atsunobu
    Yawata, Nobuyo
    Sonoda, Koh-Hei
    IMMUNOLOGICAL MEDICINE, 2019, 42 (02) : 79 - 83
  • [6] Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
    Al-Julandani, D. A.
    Bagri, N. K.
    Tsang, N.
    Clarke, S.
    Upadhyay, A.
    Guly, C.
    Ramanan, A., V
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [7] Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis
    Hoy, Sheridan M.
    BIODRUGS, 2017, 31 (02) : 135 - 142
  • [8] Adalimumab for non-infectious uveitis: is it cost-effective?
    Bermejo, Inigo
    Squires, Hazel
    Poku, Edith N.
    Cooper, Katy
    Stevens, John W.
    Hamilton, Jean
    Wong, Ruth
    Pearce, Ian
    Quhill, Fahd Mohammed
    Denniston, Alastair K.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (11) : 1633 - 1638
  • [9] Adalimumab for the treatment of non-infectious uveitis: an updated review
    Kubaisi, Buraa
    Syeda, Sarah
    Schmidt, Alexander
    Foster, C. Stephen
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (02): : 201 - 206
  • [10] Adalimumab in Patients with Active and Inactive Non-infectious Uveitis
    Ohno, S.
    Nguyen, Q. D.
    Dick, A.
    Jaffe, G.
    Brezin, A.
    Song, A. P.
    Kron, M.
    Camez, A.
    Tari, S.
    SWISS MEDICAL WEEKLY, 2016, 146 : 8S - 8S
12345